Trillium Therapeutics Inc
Trillium is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Business Model:
Revenue: $148k
Employees: 1,001-5,000
Industries / Tags:
Detailed Trillium Therapeutics Inc Information
Trillium Therapeutics Inc was acquired by
Pfizer.
The acquisition happend on 2021-08-23.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 100 Cambridgepark Drive
City: Cambridge
State: MA
Zip: 02140
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$25M
Raised Total:$45M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Trillium is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Contact Phone:
+18574127029
Contact Email:
Trillium Therapeutics Inc went public on 9/10/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/10/2020
Ticker Symbol:
TRIL
IPO Price:
$13/share
Amount Raised:
$130M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2017 | Private Placement | $20M | 9/2020 | Post-IPO Equity | 2 | $25M |
Frazier Healthcare Partners Pfizer Breakthrough Growth Initiative Pfizer Breakthrough Growth Initiative Frazier Healthcare Partners Pfizer Breakthrough Growth Initiative Pfizer Breakthrough Growth Initiative |
1/2017 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
1/2004 | Seed Round | 1 | - |
BDC Venture Capital BDC Venture Capital |
12/2017 | Post-IPO Equity | $20M | 5/2011 | Post-IPO Equity | $1M | 1/2017 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
1/2004 | Seed Round | 1 | - |
BDC Venture Capital BDC Venture Capital |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2016 | Fluorinov Pharma |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
